Grant: CIHR Fellowship
Direct Payment
$90,000.00
Molecular mechanisms underlying TH17 lymphocytes-mediated neuronal damage in Multiple Sclerosis
EF 2013-14
Résumé
Damage to neurons, the core cells of the brain, underlies long-term motor, sensory and cognitive deficits experienced by people with MS. Identifying treatments that would help to preserve and improve neuronal function is thus crucial to improve long-term deficits in MS.
Damage to neurons in MS is secondary to the presence of inflammatory white blood cells (immune cells) in the brain. These infiltrating immune cells can prove deleterious (cause distress and kill) but also beneficial (help to clean the myelin debris and to start remyelination) to cells of the brain. By identifying the subsets of immune cells that are deleterious and by specifically restricting their interactions with brain cells, we could decrease MS lesion formation and neuronal damage without impairing the defence and regeneration capacities of the brain. We know that TH17 cells, a subset of immune cells incriminated in MS, can make direct contact with neurons and cause neuronal injury. We want to uncover how this contact is made, using co-cultures of neurons and TH17 cells of human and mice. We will use blockers of adhesion molecules expressed specifically by TH17 cells to decrease their capacity to contact and harm neurons. Once we will have identified relevant molecules and blockers, we will confirm their importance in the mouse model of MS using live imaging of TH17 cells in the brain, looking at their contact with neurons and at the distress signals from the neurons. We hope to decrease the immune-mediated neuronal injury without impairing the brain resistance to infection with blockers of TH17-specific adhesion molecules. While available MS treatments decrease clinical relapses, their impact on neuronal injury and long-term disability is still debated. This project will open up new perspectives to specifically decrease immune-mediated neuronal damage processes in MS, with the ultimate goal of identifying new pharmacological targets to preserve brain function in MS.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Germany
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
300689
Name
Larochelle Catherine
Country
Germany
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Health Professional Awards - Fellowships
Projecttitle
Molecular mechanisms underlying TH17 lymphocytes-mediated neuronal damage in Multiple Sclerosis
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$90,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Adhesion Molecules; Cell Isolation; Chemokines And Chemokine Receptors; Culture; Eae (Animal Models); Immunohistofluorescence; Intravital Two-Photon Microscopy; Multiple Sclerosis; Neuroinflammation; Neurons; Skewing; Th17 Lymphocytes
Abstract
Damage to neurons, the core cells of the brain, underlies long-term motor, sensory and cognitive deficits experienced by people with MS. Identifying treatments that would help to preserve and improve neuronal function is thus crucial to improve long-term deficits in MS.
Damage to neurons in MS is secondary to the presence of inflammatory white blood cells (immune cells) in the brain. These infiltrating immune cells can prove deleterious (cause distress and kill) but also beneficial (help to clean the myelin debris and to start remyelination) to cells of the brain. By identifying the subsets of immune cells that are deleterious and by specifically restricting their interactions with brain cells, we could decrease MS lesion formation and neuronal damage without impairing the defence and regeneration capacities of the brain. We know that TH17 cells, a subset of immune cells incriminated in MS, can make direct contact with neurons and cause neuronal injury. We want to uncover how this contact is made, using co-cultures of neurons and TH17 cells of human and mice. We will use blockers of adhesion molecules expressed specifically by TH17 cells to decrease their capacity to contact and harm neurons. Once we will have identified relevant molecules and blockers, we will confirm their importance in the mouse model of MS using live imaging of TH17 cells in the brain, looking at their contact with neurons and at the distress signals from the neurons. We hope to decrease the immune-mediated neuronal injury without impairing the brain resistance to infection with blockers of TH17-specific adhesion molecules. While available MS treatments decrease clinical relapses, their impact on neuronal injury and long-term disability is still debated. This project will open up new perspectives to specifically decrease immune-mediated neuronal damage processes in MS, with the ultimate goal of identifying new pharmacological targets to preserve brain function in MS.
Competitiondate
201311
Approvedterm2
1 yr 6 mths
Pinamesdelim
Larochelle, Catherine
Approvedterm
1 an 6 mois
Cihrcontribution2
~ $90,000~ $0~